acute myocardial infarction
Conditions
Interventions
Levosimendan combined with norepinephrine group:Levosimendan 12.5mg (5ml) was mixed with 5% glucose injection to 50ml (250ug/ml), and norepinephrine was added to 50ml (0.1 µ g/ml) by multiplying the a
Norepinephrine group:A single group was treated with norepinephrine, which was administered intravenously. Norepinephrine was added to 50ml (0.1 µ g/kg) of 5% glucose injection at an initial rate of 0
Sponsors
Fushun People's Hospital, Fushun
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Participants aged over 18 with acute myocardial infarction who had a systolic/diastolic blood pressure lower than 90/60 mmHg (1 mmHg = 0.133 kPa) or a decrease in mean arterial pressure greater than 30 mmHg; 2. Urine output less than 0.5 ml/kg·h; 3. Participants who had signed informed consent form were included in the study.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Individuals with a history of mental illness; 3. Severe liver dysfunction (Child Pugh grade C); 4. Severe kidney dysfunction (creatinine clearance rate<30ml/min), 5. Participants with II-III degree atrioventricular block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 28 day survival rate;90 day survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event incidence rate;Post-treatment outcome;Length of hospital stay; | — |
Countries
China
Contacts
Public ContactQiang Li
Fushun People's Hospital, Fushun
Outcome results
None listed